Internal Medicine · Albany, NY
NPI
1194716225
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
47 New Scotland Ave
Albany, NY, 12208
Phone (518) 262-6279
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$397K
4,900 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kanwarjit S Khera prescribed most often to Medicare patients was Atorvastatin Calcium, with 292 prescriptions and refills. In total Kanwarjit S Khera wrote 4,900 Medicare prescriptions that cost $397K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 292 | 681 | 123 | $5,067 |
| Levothyroxine Sodium Generic | 187 | 372 | 63 | $3,241 |
| Amlodipine Besylate Generic | 171 | 345 | 66 | $2,331 |
| Gabapentin Generic | 154 | 238 | 50 | $5,285 |
| Furosemide Generic | 151 | 278 | 55 | $1,656 |
| Lisinopril Generic | 134 | 307 | 53 | $1,919 |
| Famotidine Generic | 128 | 232 | 53 | $2,323 |
| Trazodone Hcl Generic | 115 | 181 | 45 | $1,897 |
| Losartan Potassium Generic | 109 | 222 | 46 | $1,993 |
| Potassium Chloride Generic | 108 | 205 | 37 | $2,178 |
| Tamsulosin Hcl Generic | 105 | 209 | 44 | $1,949 |
| Mirtazapine Generic | 102 | 130 | 26 | $4,747 |
| Metoprolol Tartrate Generic | 98 | 191 | 44 | $1,277 |
| Divalproex Sodium Generic | 78 | 93 | 19 | $5,130 |
| Metformin Hcl Generic | 76 | 120 | 16 | $1,622 |
Brand drugs: - claims; generic drugs: 4,412 claims; opioid claims: 60.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kanwarjit S Khera were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.